Answers are grounded in this paper and cite their sources.
Among patients undergoing mechanical ventilation in the ICU, those who received early dexmedetomidine for sedation had a rate of death at 90 days similar to that in the usual-care group and required supplemental sedatives to achieve the prescribed level of sedation. More adverse events were reported in the dexmedetomidine group than in the usual-care group. (Funded by the National Health and Medical Research Council of Australia and others; SPICE III ClinicalTrials.gov number, NCT01728558.).
No takes yet. Share an insight, caveat, or question.
Shehabi et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: